Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRHa in Fertility Preservation Surgery for Ovarian Malignancy
NCT03882190Unknown
- Sponsor
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
- Start
- Apr 2019
- Primary completion
- Mar 2021
- Modality
- Peptides
01
Overview
Randomised, open-label trial of gonadotropin-releasing hormone agonist in ovarian cancer (2 arms), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Primary endpoints: Content of FSH, LH, E2, P, T, and PRL at 1 year, Volume of ovary at 1 year and 1 more. Status: unknown.
02
Drugs
gonadotropin-releasing hormone agonist
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT03882190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03882190.